Different requirements for alpha-galactosylceramide and recombinant IL-12 antitumor activity in the treatment of C-26 colon carcinoma hepatic metastases.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/FC691663.svg?ark=w1%2F20260515%2FFC691663&value=id)](https://nobleid.org/work/w1/20260515/FC691663)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors